Research Output per year
Research Output 1983 2019
- 100 - 150 out of 407 results
- Publication Year, Title (descending)
FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: A meta-analysis on 1134 patients from two prospective cohorts
Ghesquières, H., Larrabee, B. R., Haioun, C., Link, B. K., Verney, A., Slager, S. L., Ketterer, N., Ansell, S. M., Delarue, R., Maurer, M. J., Fitoussi, O., Habermann, T. M., Peyrade, F., Dogan, A., Molina, T. J., Novak, A. J., Tilly, H., Cerhan, J. R. & Salles, G., 2016, (Accepted/In press) In : Hematological Oncology.Research output: Contribution to journal › Article
Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma
Chen, R., Gopal, A. K., Smith, S. E., Ansell, S. M., Rosenblatt, J. D., Savage, K. J., Connors, J. M., Engert, A., Larsen, E. K., Huebner, D., Fong, A. & Younes, A., Sep 22 2016, In : Blood. 128, 12, p. 1562-1566 5 p.Research output: Contribution to journal › Article
Follicular lymphoma tregs have a distinct transcription profile impacting their migration and retention in the malignant lymph node
Nedelkovska, H., Rosenberg, A. F., Hilchey, S. P., Hyrien, O., Burack, W. R., Quataert, S. A., Baker, C. M., Azadniv, M., Welle, S. L., Ansell, S. M., Kim, M. & Bernstein, S. H., May 1 2016, In : PLoS One. 11, 5, e0155347.Research output: Contribution to journal › Article
Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes
Machiela, M. J., Lan, Q., Slager, S. L., Vermeulen, R. C. H., Teras, L. R., Camp, N. J., Cerhan, J. R., Spinelli, J. J., Wang, S. S., Nieters, A., Vijai, J., Yeager, M., Wang, Z., Ghesquières, H., McKay, J., Conde, L., de Bakker, P. I. W., Cox, D. G., Burdett, L., Monnereau, A. & 100 others, , Apr 15 2016, In : Human Molecular Genetics. 25, 8, p. 1663-1676 14 p., ddw027.Research output: Contribution to journal › Article
Glancing at the complex biology of T-cells through the microenvironment of Hodgkin lymphoma*
Villasboas Bisneto, J. J. C. . & Ansell, S. M., Oct 28 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-3 3 p.Research output: Contribution to journal › Article
Hodgkin lymphoma: MOPP chemotherapy to PD-1 blockade and beyond
Ansell, S. M., Jan 1 2016, In : American Journal of Hematology. 91, 1, p. 109-112 4 p.Research output: Contribution to journal › Article
Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management
Ansell, S. M., Apr 1 2016, In : American Journal of Hematology. 91, 4, p. 434-442 9 p.Research output: Contribution to journal › Article
How to select the frontline treatment for a patient with peripheral T-cell lymphoma
Ansell, S. M., Apr 2 2016, In : Leukemia and Lymphoma. 57, 4, p. 783-788 6 p.Research output: Contribution to journal › Article
Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop
Houot, R., Gaulard, P., Schreiber, R., Mellman, I., Lambotte, O., Coulie, P. G., Fest, T., Korman, A., Levy, R., Shipp, M., Tarte, K., Kohrt, H., Marabelle, A., Ansell, S. M., Watier, H., van Elsas, A., Balakumaran, A., Arce Vargas, F., Quezada, S. A., Salles, G. & 1 others, , Jul 2 2016, In : OncoImmunology. 5, 7, e1186323.Research output: Contribution to journal › Article
Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma
Luchtel, R., Razidlo, G., Dasari, S., Zeng, Y., Hu, G., Knudson, R. A., Greipp, P. T., Davila, J. I., Johnson, S. H., Porcher, J. C., Smadbeck, J., Eckloff, B. W., Billadeau, D. D., Kurtin, P. J., Mc Niven, M. A., Link, B. K., Ansell, S. M., Cerhan, J. R., Asmann, Y., Vasmatzis, G. & 1 others, , Sep 1 2016, In : Blood. 128, 9, p. 1234-1245 12 p.Research output: Contribution to journal › Article
Large b-cell transformation in nodular lymphocyte-predominant hodgkin lymphoma: 40-year experience from a single institution
Kenderian, S., Habermann, T. M., Macon, W. R., Ristow, K. M., Ansell, S. M., Colgan, J. P., Johnston, P. B., Inwards, D. J., Markovic, S. N., Micallef, I., Thompson, C. A., Porrata, L. F., Martenson, J. A., Witzig, T. E. & Nowakowski, G. S., Apr 21 2016, In : Blood. 127, 16, p. 1960-1966 7 p.Research output: Contribution to journal › Article
Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations
King, R., Gonsalves, W., Ansell, S. M., Greipp, P. T., Frederick, L. A., Viswanatha, D. S., He, R., Kyle, R. A., Gertz, M., Kapoor, P., Morice, W. G. & Howard, M. T., Jun 1 2016, In : American Journal of Clinical Pathology. 145, 6, p. 843-851 9 p.Research output: Contribution to journal › Article
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial
Younes, A., Santoro, A., Shipp, M., Zinzani, P. L., Timmerman, J. M., Ansell, S. M., Armand, P., Fanale, M., Ratanatharathorn, V., Kuruvilla, J., Cohen, J. B., Collins, G., Savage, K. J., Trneny, M., Kato, K., Farsaci, B., Parker, S. M., Rodig, S., Roemer, M. G. M., Ligon, A. H. & 1 others, , Sep 1 2016, In : The Lancet Oncology. 17, 9, p. 1283-1294 12 p.Research output: Contribution to journal › Article
Nivolumab for the treatment of classical Hodgkin lymphoma after failure of autologous stem cell transplant and brentuximab
Villasboas Bisneto, J. J. C. . & Ansell, S. M., Jan 2 2016, In : Expert Review of Anticancer Therapy. 16, 1, p. 5-12 8 p.Research output: Contribution to journal › Article
Nivolumab in patients with relapsed or refractory hematologic malignancy: Preliminary results of a phase ib study
Lesokhin, A. M., Ansell, S. M., Armand, P., Scott, E. C., Halwani, A., Gutierrez, M., Millenson, M. M., Cohen, A. D., Schuster, S. J., Lebovic, D., Dhodapkar, M., Avigan, D., Chapuy, B., Ligon, A. H., Freeman, G. J., Rodig, S. J., Cattry, D., Zhu, L., Grosso, J. F., Brigid Bradley Garelik, M. & 3 others, , Aug 10 2016, In : Journal of Clinical Oncology. 34, 23, p. 2698-2704 7 p.Research output: Contribution to journal › Article
Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma
Maurer, M. J., Jais, J. P., Ghesquières, H., Witzig, T. E., Hong, F., Haioun, C., Thompson, C. A., Thieblemont, C., Micallef, I., Porrata, L. F., Ribrag, V., Nowakowski, G. S., Casasnovas, O., Bologna, S., Morschhauser, F., Morrison, V. A., Peterson, B. A., Macon, W. R., Copie-Bergman, C., Feldman, A. L. & 13 others, , Feb 1 2016, In : American Journal of Hematology. 91, 2, p. 179-184 6 p.Research output: Contribution to journal › Article
Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy
Cheson, B. D., Ansell, S. M., Schwartz, L., Gordon, L. I., Advani, R., Jacene, H. A., Hoos, A., Barrington, S. F. & Armand, P., Nov 24 2016, In : Blood. 128, 21, p. 2489-2496 8 p.Research output: Contribution to journal › Article
Role of the tumor microenvironment in mature B-cell lymphoid malignancies
Fowler, N. H., Cheah, C. Y., Gascoyne, R. D., Gribben, J., Neelapu, S. S., Ghia, P., Bollard, C., Ansell, S. M., Curran, M., Wilson, W. H., O’Brien, S., Grant, C., Little, R., Zenz, T., Nastoupil, L. J. & Dunleavy, K., Apr 30 2016, In : Haematologica. 101, 5, p. 531-540 10 p.Research output: Contribution to journal › Article
Targeting the PD-1 pathway in patients with relapsed classic Hodgkin lymphoma following allogeneic stem cell transplant is safe and effective
Villasboas Bisneto, J. J. C. ., Ansell, S. M. & Witzig, T. E., Mar 15 2016, In : Oncotarget. 7, 11, p. 13260-13264 5 p.Research output: Contribution to journal › Article
The landscape of new drugs in lymphoma
Younes, A., Ansell, S. M., Fowler, N., Wilson, W., de Vos, S., Seymour, J., Advani, R., Forero, A., Morschhauser, F., Kersten, M. J., Tobinai, K., Zinzani, P. L., Zucca, E., Abramson, J. & Vose, J., Dec 29 2016, (Accepted/In press) In : Nature Reviews Clinical Oncology.Research output: Contribution to journal › Article
The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: Multiple myeloma, lymphoma, and acute leukemia
Boyiadzis, M., Bishop, M. R., Abonour, R., Anderson, K. C., Ansell, S. M., Avigan, D., Barbarotta, L., Barrett, A. J., Besien, K., Bergsagel, P. L., Borrello, I., Brody, J., Brufsky, J., Cairo, M., Chari, A., Cohen, A., Cortes, J., Forman, S. J., Friedberg, J. W., Fuchs, E. J. & 28 others, , Dec 20 2016, In : Journal for ImmunoTherapy of Cancer. 4, 1, 90.Research output: Contribution to journal › Article
Treatment of HIV/AIDS associated cancers with immunotherapy targeting PD-1/PD-L1 instead of chemotherapy
Kasi, P. M., Block, M. S. & Ansell, S. M., Jan 1 2016, In : Medical Hypotheses. 86, p. 129-131 3 p.Research output: Contribution to journal › Article
Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection
Kapoor, P., Paludo, J. & Ansell, S. M., Mar 1 2016, In : Current Treatment Options in Oncology. 17, 3, 16.Research output: Contribution to journal › Article
Where do programmed death-1 inhibitors fit in the management of malignant lymphoma?
Ansell, S. M., Feb 1 2016, In : Journal of Oncology Practice. 12, 2, p. 101-106 6 p.Research output: Contribution to journal › Article
A genome-wide association study of marginal zone lymphoma shows association to the HLA region
Vijai, J., Wang, Z., Berndt, S. I., Skibola, C. F., Slager, S. L., De Sanjose, S., Melbye, M., Glimelius, B., Bracci, P. M., Conde, L., Birmann, B. M., Wang, S. S., Brooks-Wilson, A. R., Lan, Q., De Bakker, P. I. W., Vermeulen, R. C. H., Portlock, C., Ansell, S. M., Link, B. K., Riby, J. & 82 others, , Jan 8 2015, In : Nature Communications. 6, 6751.Research output: Contribution to journal › Article
Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: A randomized, double-blind, placebo-controlled phase 2b trial
Fayad, L., Ansell, S. M., Advani, R., Coiffier, B., Stuart, R., Bartlett, N. L., Forero-Torres, A., Kuliczkowski, K., Belada, D., Ng, E. & Drachman, J. G., Sep 2 2015, In : Leukemia and Lymphoma. 56, 9, p. 2569-2578 10 p.Research output: Contribution to journal › Article
DNA methylation in lymphoma: An opportunity?
Ansell, S. M., Mar 19 2015, In : Blood. 125, 12, p. 1848-1849 2 p.Research output: Contribution to journal › Article
Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma
Gopal, A. K., Chen, R., Smith, S. E., Ansell, S. M., Rosenblatt, J. D., Savage, K. J., Connors, J. M., Engert, A., Larsen, E. K., Chi, X., Sievers, E. L. & Younes, A., Feb 19 2015, In : Blood. 125, 8, p. 1236-1243 8 p.Research output: Contribution to journal › Article
Early treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates
Zent, C. S., Call, T. G., Bowen, D. A., Conte, M. J., LaPlant, B. R., Witzig, T. E., Ansell, S. M. & Weiner, G. J., Aug 3 2015, In : Leukemia and Lymphoma. 56, 8, p. 2373-2378 6 p.Research output: Contribution to journal › Article
Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma
Mir, M. A., Maurer, M. J., Ziesmer, S. C., Slager, S. L., Habermann, T. M., Macon, W. R., Link, B. K., Syrbu, S., Witzig, T. E., Friedberg, J. W., Press, O., LeBlanc, M., Cerhan, J. R., Novak, A. J. & Ansell, S. M., Feb 5 2015, In : Blood. 125, 6, p. 992-998 7 p.Research output: Contribution to journal › Article
Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma
Chakraborty, R., Kapoor, P., Ansell, S. M. & Gertz, M., Oct 3 2015, In : Expert Review of Anticancer Therapy. 15, 10, p. 1143-1156 14 p.Research output: Contribution to journal › Article
Expression of the chemokine receptor gene, CCR8, is associated with DUSP22 rearrangements in anaplastic large cell lymphoma
Xing, X., Flotte, T. J., Law, M. E., Blahnik, A. J., Chng, W. J., Huang, G., Knudson, R. A., Ketterling, R. P., Porcher, J. C., Ansell, S. M., Sidhu, J., Dogan, A. & Feldman, A. L., Sep 23 2015, In : Applied Immunohistochemistry and Molecular Morphology. 23, 8, p. 580-589 10 p.Research output: Contribution to journal › Article
Genome-Wide association study of event-free survival in diffuse large B-cell lymphoma treated with immunochemotherapy
Ghesquieres, H., Slager, S. L., Jardin, F., Veron, A. S., Asmann, Y., Maurer, M. J., Fest, T., Habermann, T. M., Bene, M. C., Novak, A. J., Mareschal, S., Haioun, C., Lamy, T., Ansell, S. M., Tilly, H., Witzig, T. E., Weiner, G. J., Feldman, A. L., Dogan, A., Cunningham, J. M. & 7 others, , Nov 20 2015, In : Journal of Clinical Oncology. 33, 33, p. 3930-3937 8 p.Research output: Contribution to journal › Article
Hodgkin lymphoma: Diagnosis and treatment
Ansell, S. M., 2015, In : Mayo Clinic Proceedings. 90, 11, p. 1574-1583 10 p.Research output: Contribution to journal › Article
Ibrutinib for the treatment of Waldenström macroglobulinemia
Chakraborty, R., Kapoor, P., Ansell, S. M. & Gertz, M., Sep 3 2015, In : Expert Review of Hematology. 8, 5, p. 569-579 11 p.Research output: Contribution to journal › Article
IL-10 induces the development of immunosuppressive CD14+ HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma
Xiu, B., Lin, Y., Grote, D. M., Ziesmer, S. C., Gustafson, M., Maas, M. L., Zhang, Z., Dietz, A. B., Porrata, L. F., Novak, A. J., Liang, A. B., Yang, Z. Z. & Ansell, S. M., Jul 31 2015, In : Blood Cancer Journal. 5, 7, e328.Research output: Contribution to journal › Article
Immunologic Autograft Engineering and Survival in Non-Hodgkin Lymphoma
Porrata, L. F., Burgstaler, E. A., Winters, J. L., Jacob, E. K., Gastineau, D. A., Suman, V. J., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Nevala, W. & Markovic, S. N., Sep 23 2015, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.Research output: Contribution to journal › Article
Infused autograft lymphocyte-to-monocyte ratio and survival in T-cell lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation
Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Hogan, W. & Markovic, S. N., Jul 3 2015, In : Journal of Hematology and Oncology. 8, 1, 5.Research output: Contribution to journal › Article
Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma
Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Hogan, W. & Markovic, S. N., Feb 2 2015, In : Journal of Blood Medicine. 6, p. 45-53 9 p.Research output: Contribution to journal › Article
Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-cell lymphoma: A phase II study
Nowakowski, G. S., LaPlant, B., Macon, W. R., Reeder, C. B., Foran, J. M., Nelson, G. D., Thompson, C. A., Rivera, C. E., Inwards, D. J., Micallef, I., Johnston, P. B., Porrata, L. F., Ansell, S. M., Gascoyne, R. D., Habermann, T. M. & Witzig, T. E., Jan 20 2015, In : Journal of Clinical Oncology. 33, 3, p. 251-257 7 p.Research output: Contribution to journal › Article
Non-Hodgkin Lymphoma: Diagnosis and Treatment
Ansell, S. M., Aug 1 2015, In : Mayo Clinic Proceedings. 90, 8, p. 1152-1163 12 p.Research output: Contribution to journal › Article
Non-Hodgkin lymphoma, body mass index, and cytokine polymorphisms: A pooled analysis from the interlymph consortium
Kane, E., Skibola, C. F., Bracci, P. M., Cerhan, J. R., Costas, L., Smedby, K. E., Holly, E. A., Maynadié, M., Novak, A. J., Lightfoot, T. J., Ansell, S. M., Smith, A. G., Liebow, M., Melbye, M., Morton, L., De Sanjosé, S., Slager, S. L., Wang, S. S., Zhang, Y., Zheng, T. & 1 others, , Jul 1 2015, In : Cancer Epidemiology Biomarkers and Prevention. 24, 7, p. 1061-1070 10 p.Research output: Contribution to journal › Article
Novel agents in the therapy of Hodgkin lymphoma
Ansell, S. M., 2015, In : American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting. p. e479-e482Research output: Contribution to journal › Article
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma
Ansell, S. M., Lesokhin, A. M., Borrello, I., Halwani, A., Scott, E. C., Gutierrez, M., Schuster, S. J., Millenson, M. M., Cattry, D., Freeman, G. J., Rodig, S. J., Chapuy, B., Ligon, A. H., Zhu, L., Grosso, J. F., Kim, S. Y. O., Timmerman, J. M., Shipp, M. A. & Armand, P., Jan 22 2015, In : The New England journal of medicine. 372, 4, p. 311-319 9 p.Research output: Contribution to journal › Article
PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival
Yang, Z. Z., Grote, D. M., Ziesmer, S. C., Xiu, B., Novak, A. J. & Ansell, S. M., Jan 1 2015, In : Blood Cancer Journal. 5, 2, e281.Research output: Contribution to journal › Article
Phase II clinical trials for Waldenstrom's macroglobulinemia
Chakraborty, R., Ansell, S. M., Kapoor, P. & Gertz, M., May 1 2015, In : Expert Opinion on Orphan Drugs. 3, 5, p. 537-547 11 p.Research output: Contribution to journal › Article
Survival in patients with limited-stage peripheral T-cell lymphomas
Briski, R., Feldman, A. L., Bailey, N. G., Lim, M. S., Ristow, K., Habermann, T. M., Macon, W. R., Inwards, D. J., Colgan, J. P., Nowakowski, G. S., Kaminski, M. S., Witzig, T. E., Ansell, S. M. & Wilcox, R. A., Jun 1 2015, In : Leukemia and Lymphoma. 56, 6, p. 1665-1670 6 p.Research output: Contribution to journal › Article
Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells
Chitta, K., Paulus, A., Akhtar, S., Blake, M. K. K., Caulfield, T., Novak, A. J., Ansell, S. M., Advani, P., Ailawadhi, S., Sher, T., Linder, S. & Chanan Khan, A. A., May 1 2015, In : British Journal of Haematology. 169, 3, p. 377-390 14 p.Research output: Contribution to journal › Article
Targeting immune checkpoints in lymphoma
Ansell, S. M., Jul 1 2015, In : Current Opinion in Hematology. 22, 4, p. 337-342 6 p.Research output: Contribution to journal › Article
Targeting the spleen tyrosine kinase with fostamatinib as a strategy against Waldenström Macroglobulinemia
Kuiatse, I., Baladandayuthapani, V., Lin, H. Y., Thomas, S. K., Bjorklund, C. C., Weber, D. M., Wang, M., Shah, J. J., Zhang, X. D., Jones, R. J., Ansell, S. M., Yang, G., Treon, S. P. & Orlowski, R. Z., Jun 1 2015, In : Clinical Cancer Research. 21, 11, p. 2538-2545 8 p.Research output: Contribution to journal › Article